Editas Medicine, Inc. (EDIT) EDIT-301 Clinical Update 2022 - (Transcript)
Editas Medicine(EDIT)2022-12-07 01:11
Editas Medicine, Inc. (NASDAQ:EDIT) EDIT-301 Clinical Update Call December 6, 2022 8:00 AM ET Company Participants Ron Moldaver - Investor Relations Gilmore O’Neill - President and Chief Executive Officer Baisong Mei - Senior Vice President and Chief Medical Officer Mark Shearman - Chief Scientific Officer Conference Call Participants Phil Nadeau - Cowen Securities Gena Wang - Barclays Matthew Harrison - Morgan Stanley Joon Lee - Truist Securities Joel Beatty - Baird Greg Harrison - BofA Yanan Zhu - Wells F ...